Results 221 to 230 of about 34,767 (273)
Molecular Detection of <i>Blastocystis</i> ST2 and ST4 and Exploratory 16S rRNA Gene Community Profiles in a 12-Week Dairy-Intervention Pilot Study. [PDF]
MicroorganismsTsokkou P +6 more
europepmc +1 more source
Isolation, Pathogenicity, and Genomic Analysis of a Virulent <i>Aeromonas salmonicida</i> ST2 Strain from <i>Thymallus arcticus grubei</i>. [PDF]
Biology (Basel)Zhao R +6 more
europepmc +1 more source
Comprehensive identification of sequence types belonging to <i>Acinetobacter baumannii</i> clonal complexes. [PDF]
Microb GenomHall RM, Harmer CJ.
europepmc +1 more source
The role of ST2 and ST2 genetic variants in schistosomiasis [PDF]
Journal of Allergy and Clinical Immunology, 2017 Chronic schistosomiasis and its severe complication, periportal fibrosis, are characterized by a predominant Th2 response. To date, specific single nucleotide polymorphisms in ST2 have been some of the most consistently associated genetic variants for asthma.We investigated the role of ST2 (a receptor for the Th2 cytokine IL-33) in chronic and late ...
Li Gao, Huifang Liang, Xiaoping Chen
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Biology of ST2: The International ST2 Consensus Panel
The American Journal of Cardiology, 2015ST2 is a member of the interleukin 1 receptor family with 2 main isoforms: transmembrane or cellular (ST2L) and soluble or circulating (sST2) forms. ST2 is the receptor of the IL-33, which is an IL-1-like cytokine that can be secreted by living cells in response to cell damage.
Domingo A, Pascual-Figal +1 more
+7 more sources
Heart Failure Clinics, 2018
Suppression of tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family, whose role was originally established in the context of inflammatory and autoimmune diseases. More recently, testing for ST2 has been used in the setting of cardiovascular disease.
Cian P McCarthy, James Januzzi
exaly +3 more sources
Suppression of tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family, whose role was originally established in the context of inflammatory and autoimmune diseases. More recently, testing for ST2 has been used in the setting of cardiovascular disease.
Cian P McCarthy, James Januzzi
exaly +3 more sources
The American Journal of Cardiology, 2015
In recent years, numerous studies have focused on the use of soluble ST2 (sST2) as a clinical biomarker for cardiovascular disease. However, much preclinical data points to involvement of the ST2 pathway in inflammation, and specifically in pulmonary inflammation. This report summarizes the current body of clinical data suggesting the potential role of
Ednan K, Bajwa +2 more
openaire +2 more sources
In recent years, numerous studies have focused on the use of soluble ST2 (sST2) as a clinical biomarker for cardiovascular disease. However, much preclinical data points to involvement of the ST2 pathway in inflammation, and specifically in pulmonary inflammation. This report summarizes the current body of clinical data suggesting the potential role of
Ednan K, Bajwa +2 more
openaire +2 more sources
ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus Panel
The American Journal of Cardiology, 2015ST2 is a member of the interleukin (IL) 1 receptor family that exists in 2 forms, a transmembrane receptor (ST2L) and a soluble receptor (sST2). The ligand of ST2 is IL-33, known to be involved in reducing tissue fibrosis and myocyte hypertrophy in mechanically strained hearts.
Januzzi, James L. +2 more
openaire +2 more sources